Page 4 - Patanjali Ayurved

Ruchi Soya hits upper circuit on buyout of Patanjali's food retail business

The board also approved to change company's name from Ruchi Soya Industries to Patanjali Foods.

Ruchi Soya to change the name of the company to Patanjali Foods

The board of Ruchi Soya also accorded its in-principle approval for evaluating the most efficient mode of enhancing synergies with Patanjali Ayurved Ltd's food portfolio on an arm's-length basis

Ruchi Soya to launch FPO on March 24; looking to raise Rs 4,300 cr

Edible oil firm Ruchi Soya, which is owned by Baba Ramdev-led Patanjali Ayurved, will hit the capital market with its follow-on public offer (FPO) on March 24 to raise up to Rs 4,300 cr.

Ruchi Soya buys biscuits, noodles unit from Patanjali for Rs 65 cr

Ruchi Soya to use FPO fund to repay debt

Ramdev has no ill-will against modern science, its practitioners: Patanjali

Patanjali Yogpeeth Trust denied allegations by the Indian Medical Association (IMA) that yoga guru Ramdev has misled people by making "unlearned" statements modern medicine

Patanjali Ayurved raises Rs 175 cr through non-convertible debentures

Baba Ramdev-led Patanjali Ayurved on Tuesday said it has raised Rs 175 crore by issuing non-convertible debentures (NCDs).

Patanjali refutes IMA's claims; releases research papers on Coronil

To support its argument, Patanjali has released a bunch of scientific papers on its research for a Covid-19 medicine that was published in popular peer-reviewed journals

Coronil has got Ayush Ministry certification as per WHO scheme: Patanjali

The firm said its Coronil tablet has received certification from the Ayush Ministry as a medicine supporting COVID-19 treatment as per the World Health Organization's certification scheme

India's super-rich club sees 10 new entrants in 2020; wealth up 33%

Ramdev, partner see biggest jump in wealth in percentage terms

Baba Ramdev on board of Ruchi Soya; brother Ram Bharat to be MD

Ruchi Soya Industries Ltd in a notice to shareholders sought approval for appointment of Ram Bharat, 41, as the managing director of the company.

Patanjali Ayurved far from glory days even as revenue and profit rise

While the company's operating revenue grew 6%, net profit jumped 22% in FY2020

Patanjali Ayurved's FY20 net rises 21.56% to Rs 424 cr, expenses up 5.34%

Total expenses of Patanjali Ayurved were up 5.34 per cent to Rs 8,521.44 crore

BS READS: Ramdev's low-key brother emerges from the shadows with Ruchi Soya

Baba Ramdev's fame drives Patanjali - he evolves broad strategies and Acharya Balkrishna acts as MD. But there is also a third man in Patanjali's power index: Ram Bharat, Ramdev's younger brother

Sebi's higher float proposal for IBC firms could run into hurdles

Several legal experts plan to highlight the challenges in implementing all three options recommended by the regulator

Madras HC stays order barring Patanjali Ayurved from using mark 'Coronil'

Division Bench grants the company relief for two weeks

BS READS: The mystery investor who made a killing in Ruchi Soya

A Delhi-based company put Rs 13 cr for a 5.94% stake in Ruchi Soya soon after it got relisted; today that investment is worth Rs 1,500 crore

Madras High Court restrains Patanjali from using trademark 'Coronil'

Justice Karthikeyan passed the order valid till July 30 on the plea of Chennai-based company Arudra Engineering Private Limited

From Patanjali's claim to U-turn on Coronil: Sequence of events

On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days

Top Headlines: Relief for pharma cos, ban to hit Chinese firms, and more

Here are the top headlines on Wednesday morning

Patanjali takes a u-turn; says never claimed to have made Covid-19 medicine

The Haridwar-based organisation has withdrawn from its earlier claim, in reply to the notice given by Uttarakhand Ayush Ministry